Palivizumab Prophylaxis for Respiratory Syncytial Virus: Examining the Evidence Around Value.
Olchanski N, Hansen RN, Pope E, D'Cruz B, Fergie J, Goldstein M, Krilov LR, McLaurin KK, Nabrit-Stephens B, Oster G, Schaecher K, Shaya FT, Neumann PJ, Sullivan SD.
Olchanski N, et al.
Open Forum Infect Dis. 2018 Feb 7;5(3):ofy031. doi: 10.1093/ofid/ofy031. eCollection 2018 Mar.
Open Forum Infect Dis. 2018.
PMID: 29516023
Free PMC article.
Review.